Sickle cell anaemia diagnosis is now more accessible in India. The government reduced the price of diagnostic kits to under Rs 50. ICMR validated 35 point-of-care tests. This follows a health technology assessment. The National Health Mission instructed states to procure kits at lower prices. This initiative supports the National Sickle Cell Elimination Programme.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RBOyZFU
via IFTTT
No comments:
Post a Comment